Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, GE HealthCare Technologies Inc (NASDAQ: GEHC) closed at $77.96 up 2.59% from its previous closing price of $75.99. In other words, the price has increased by $2.59 from its previous closing price. On the day, 4.36 million shares were traded. GEHC stock price reached its highest trading level at $78.4 during the session, while it also had its lowest trading level at $75.64.
Ratios:
For a deeper understanding of GE HealthCare Technologies Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.74. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 0.88.
On March 11, 2025, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $85 to $100. Jefferies Upgraded its Hold to Buy on January 08, 2025, whereas the target price for the stock was revised from $95 to $103.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 18 ’25 when Newcomb George A. sold 2,000 shares for $92.54 per share. The transaction valued at 185,080 led to the insider holds 7,462 shares of the business.
Rott Roland sold 3,577 shares of GEHC for $309,339 on Nov 06 ’24. The CEO, Imaging now owns 24,298 shares after completing the transaction at $86.48 per share. On Nov 06 ’24, another insider, Roland Rott, who serves as the Officer of the company, bought 3,577 shares for $86.48 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GEHC now has a Market Capitalization of 35593572352 and an Enterprise Value of 41914150912. As of this moment, GE’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.96, and their Forward P/E ratio for the next fiscal year is 15.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.78 while its Price-to-Book (P/B) ratio in mrq is 3.66. Its current Enterprise Value per Revenue stands at 2.099 whereas that against EBITDA is 11.408.
Stock Price History:
The Beta on a monthly basis for GEHC is 1.28, which has changed by -0.10298008 over the last 52 weeks, in comparison to a change of 0.17089343 over the same period for the S&P500. Over the past 52 weeks, GEHC has reached a high of $94.80, while it has fallen to a 52-week low of $57.65. The 50-Day Moving Average of the stock is 4.65%, while the 200-Day Moving Average is calculated to be 0.87%.
Shares Statistics:
For the past three months, GEHC has traded an average of 3.76M shares per day and 3650640 over the past ten days. A total of 456.56M shares are outstanding, with a floating share count of 455.23M. Insiders hold about 0.29% of the company’s shares, while institutions hold 84.74% stake in the company. Shares short for GEHC as of 1756425600 were 7357594 with a Short Ratio of 1.96, compared to 1753920000 on 9024652. Therefore, it implies a Short% of Shares Outstanding of 7357594 and a Short% of Float of 2.1300000999999997.
Earnings Estimates
The stock of GE HealthCare Technologies Inc (GEHC) is currently in the spotlight, with 15.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $1.38, with high estimates of $1.43 and low estimates of $1.2.
Analysts are recommending an EPS of between $4.55 and $3.97 for the fiscal current year, implying an average EPS of $4.48. EPS for the following year is $4.86, with 18.0 analysts recommending between $5.13 and $4.05.
Revenue Estimates
A total of 13 analysts believe the company’s revenue will be $5.07B this quarter.It ranges from a high estimate of $5.11B to a low estimate of $5.01B. As of the current estimate, GE HealthCare Technologies Inc’s year-ago sales were $4.86BFor the next quarter, 13 analysts are estimating revenue of $5.61B. There is a high estimate of $5.68B for the next quarter, whereas the lowest estimate is $5.53B.
A total of 18 analysts have provided revenue estimates for GEHC’s current fiscal year. The highest revenue estimate was $20.58B, while the lowest revenue estimate was $20.08B, resulting in an average revenue estimate of $20.43B. In the same quarter a year ago, actual revenue was $19.67BBased on 18 analysts’ estimates, the company’s revenue will be $21.36B in the next fiscal year. The high estimate is $21.71B and the low estimate is $20.78B.
